Drug
Xuesaitong Soft Capsule
Xuesaitong Soft Capsule is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_4
1
33%
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 22 (66.7%)
Phase 41 (33.3%)
Trials by Status
recruiting133%
unknown267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease
NCT06425120
unknownphase_2
Efficacy and Safety of Xuesaitong Soft Capsule for Coronary Heart Disease Unstable Angina
NCT03083119
unknownphase_2
The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
NCT01615003
Clinical Trials (3)
Showing 3 of 3 trials
NCT06425120Phase 4
Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease
NCT03083119Phase 2
Efficacy and Safety of Xuesaitong Soft Capsule for Coronary Heart Disease Unstable Angina
NCT01615003Phase 2
The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3